Evidence map›Paper›PMID 33225299›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2020

An Evaluation of the Antibacterial Properties of Tormentic Acid Congener and Extracts From

Tafadzwa Chipenzi, Genuine Baloyi, Tatenda Mudondo, Simbarashe Sithole, Godloves Fru Chi, Stanley Mukanganyama

Open access · goldAbstract read
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Resveratrol inhibits the formation ofFrontiers in veterinary science · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  6. Review
  7. Assessment of Antibacterial Efficacy ofArchives of Razi Institute · 2022
    Article
  8. The Effects of Tormentic Acid and Extracts fromTheScientificWorldJournal · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tafadzwa ChipenziSchool of Pharmacy, College of Health Sciences, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.
Genuine BaloyiSchool of Pharmacy, College of Health Sciences, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.
Tatenda MudondoSchool of Pharmacy, College of Health Sciences, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.
Simbarashe SitholeDepartment of Biochemistry, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.ORCID https://orcid.org/0000-0002-3619-229X
Godloves Fru ChiUniversity of YAOUNDE 1, P.O. Box 812, Yaoundé, Cameroon.
Stanley MukanganyamaDepartment of Biochemistry, University of Zimbabwe, Mt. Pleasant, Harare, Zimbabwe.ORCID https://orcid.org/0000-0001-6071-6439
University of Zimbabwe · ZWUniversité de Yaoundé I · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ESKAPE pathogens, namely,

Identifiers

PMID33225299
PMCPMC7669338
OpenAlexW3099355646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.